Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Medication use of study groups.

Martijn A. M. den Dekker (501762)
Marjan Zwiers (501763)
Edwin R. van den Heuvel (501764)
Lisanne C. de Vos (501765)
Andries J. Smit (371032)
Clark J. Zeebregts (501766)
Matthijs Oudkerk (79015)
Rozemarijn Vliegenthart (79011)
Joop D. Lefrandt (424871)
Douwe J. Mulder (418146)

Publication date

December 2013

DOI

10.1371/journal.pone.0083084.t002

Abstract

<p>ACEi = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker.</p

Extracted data

Related items

Treatment of hypertensive patients with high risk of CVD.

Guanyang Zou (287895)
Zhitong Zhang (733339)
John Walley (287897)
Weiwei Gong (487252)
Yunxian Yu (117562)
Ruying Hu (411617)
Jia Yin (287896)
Min Yu (120607)
Xiaolin Wei (287892)

May 2015

<p>*ACEi: Angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker</p><p>** ‘Types...

Concomitant medications use within 90 days of index discharge.

Szu-Heng Wang (761539)
Dong-Yi Chen (319219)
Yu-Sheng Lin (68720)
Chun-Tai Mao (651349)
Ming-Lung Tsai (651350)
Ming-Jer Hsieh (103100)
Chung-Chuan Chou (600857)
Ming-Shien Wen (319221)
Chun-Chieh Wang (600856)
I-Chang Hsieh (103109)
Kuo-Chun Hung (410861)
Tien-Hsing Chen (331860)

June 2015

<p>Values are n (%); ACEI = angiotensin-converting-enzyme inhibitor; ARB = angiotensin II receptor b...

August 2016

lockade of the renin angiotensin aldosterone system RAAS has been the mainstay in the management of ...

Demographic and clinical characteristics of study cohorts.

Sina Moeller (551677)
Pietro A. Canetta (551678)
Annette K. Taylor (422746)
Carolina Arguelles-Grande (551679)
Holly Snyder (195958)
Peter H. Green (551680)
Krzysztof Kiryluk (156863)
Armin Alaedini (296768)

April 2014

1<p>ACEI: Angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker.</p

Use of Medications.

Hsiao-Han Wang (429124)
Chi-Chih Hung (106523)
Daw-Yang Hwang (343487)
Mei-Chuan Kuo (106525)
Yi-Wen Chiu (106535)
Jer-Ming Chang (106541)
Jer-Chia Tsai (106527)
Shang-Jyh Hwang (5312)
Julian L. Seifter (429125)
Hung-Chun Chen (106543)

July 2013

<p>Data expressed as mean ± standard deviation, median (interquartile range) or percentage.</p><p>AC...

Patient's medication.

Hiroki Sugiyama (351211)
Kazufumi Nakamura (336712)
Hiroshi Morita (124362)
Satoshi Akagi (351212)
Yoshinori Tani (351213)
Yusuke Katayama (351214)
Nobuhiro Nishii (351215)
Toru Miyoshi (341854)
Satoshi Nagase (351216)
Kunihisa Kohno (351217)
Kengo Fukushima Kusano (351218)
Tohru Ohe (351219)
Junko Kurokawa (253979)
Tetsushi Furukawa (253981)
Hiroshi Ito (297745)

February 2013

<p>ACEI/ARB: Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.</p

Medication use.

Colin D. Chue (136552)
Nadezhda A. Wall (319159)
Nicola J. Crabtree (319161)
Daniel Zehnder (291721)
William E. Moody (319163)
Nicola C. Edwards (319164)
Richard P. Steeds (319166)
Jonathan N. Townend (319167)
Charles J. Ferro (319168)

February 2013

<p>Data are frequency (percentage). ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin ...

Subgroup Analysis of ACEI and ARB: Regular versus Potentially Contaminated Heparin.

Heiko A. Kaiser (622132)
Arbi Ben Abdallah (176559)
Nan Lin (26755)
Bethany R. Tellor (622133)
Mohammad Helwani (622134)
Jennifer R. Smith (368977)
Marc R. Moon (622135)
Michael S. Avidan (622136)

August 2014

<p>ACEI indicates angiotensin-converting-enzyme inhibitor; ARB, angiotensin-receptor blocker.</p><p>...

Summary of patient selection.

Hon-Yen Wu (286645)
Chiao-Ling Peng (503342)
Pei-Chun Chen (194576)
Chih-Kang Chiang (135324)
Chee-Jen Chang (287558)
Jenq-Wen Huang (135317)
Yu-Sen Peng (315725)
Yu-Kang Tu (41946)
Tzong-Shinn Chu (141730)
Kuan-Yu Hung (286650)
Kuo-Liong Chien (73583)

May 2017

<p>ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.</p

Prescription of the recommended therapy.

Myriam L. Montminy (2156071)
Valerie Gauvin (2156065)
Stephane Turcotte (2156077)
Alain Milot (62252)
Yvan Douville (2156068)
Isabelle Bairati (2156074)

February 2016

<p>ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin receptor blocker; CAD, coronary a...

Subgroup analyses of the included studies.

Yuan Yang (151457)
Fan Zhang (46132)
Laura Skrip (474074)
Han Lei (417024)
Suxin Luo (646401)
Kai Lu (166354)
Dayi Hu (339675)

March 2015

<p>ARB: angiotensin receptor blocker; OR: odds ratios</p><p>Subgroup analyses of the included studie...

Cumulative proportion of the incidence of hospitalization owing to fractures.

Suguru Yamamoto (721661)
Ryo Kido (721662)
Yoshihiro Onishi (721663)
Shingo Fukuma (685099)
Tadao Akizawa (316095)
Masafumi Fukagawa (721664)
Junichiro J. Kazama (721665)
Ichiei Narita (156924)
Shunichi Fukuhara (316094)

April 2015

<p>ACEI: angiotensin converting enzyme inhibitor, ARB: angiotensin II receptor blocker.</p

Prevalence of statin and angiotensin-converting enzyme inhibitor (ACEI)/ angiotensin II receptor blocker (ARB) users in the pneumonia and control groups.

Jiunn-Horng Kang (427929)
Li-Ting Kao (409065)
Herng-Ching Lin (284636)
Ta-Jung Wang (5465276)
Tsung-Yeh Yang (2194069)

June 2018

<p>Prevalence of statin and angiotensin-converting enzyme inhibitor (ACEI)/ angiotensin II receptor ...

Baseline characteristics.

Chen-Ying Hung (608395)
Kuo-Yang Wang (599645)
Tsu-Juey Wu (459389)
Yu-Cheng Hsieh (599643)
Jin-Long Huang (599641)
El-Wui Loh (608396)
Ching-Heng Lin (512565)

August 2014

<p>ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; RH = resistan...

Medical management of coronary risk factors.

Ole Ahlehoff (283243)
Lone Skov (318332)
Gunnar Gislason (324410)
Jesper Lindhardsen (283245)
Søren Lund Kristensen (283241)
Lars Iversen (324412)
Stine Lasthein (324415)
Robert Gniadecki (189822)
Tomas Norman Dam (324417)
Christian Torp-Pedersen (103282)
Peter Riis Hansen (283251)

February 2013

*<p>ACE-1; angiotensin-converting enzyme inhibitor, ARB; Angiotensin II receptor blocker.</p

Treatment of hypertensive patients with high risk of CVD.

Guanyang Zou (287895)
Zhitong Zhang (733339)
John Walley (287897)
Weiwei Gong (487252)
Yunxian Yu (117562)
Ruying Hu (411617)
Jia Yin (287896)
Min Yu (120607)
Xiaolin Wei (287892)

May 2015

<p>*ACEi: Angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker</p><p>** ‘Types...

Concomitant medications use within 90 days of index discharge.

Szu-Heng Wang (761539)
Dong-Yi Chen (319219)
Yu-Sheng Lin (68720)
Chun-Tai Mao (651349)
Ming-Lung Tsai (651350)
Ming-Jer Hsieh (103100)
Chung-Chuan Chou (600857)
Ming-Shien Wen (319221)
Chun-Chieh Wang (600856)
I-Chang Hsieh (103109)
Kuo-Chun Hung (410861)
Tien-Hsing Chen (331860)

June 2015

<p>Values are n (%); ACEI = angiotensin-converting-enzyme inhibitor; ARB = angiotensin II receptor b...

August 2016

lockade of the renin angiotensin aldosterone system RAAS has been the mainstay in the management of ...

Demographic and clinical characteristics of study cohorts.

Sina Moeller (551677)
Pietro A. Canetta (551678)
Annette K. Taylor (422746)
Carolina Arguelles-Grande (551679)
Holly Snyder (195958)
Peter H. Green (551680)
Krzysztof Kiryluk (156863)
Armin Alaedini (296768)

April 2014

1<p>ACEI: Angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker.</p

Use of Medications.

Hsiao-Han Wang (429124)
Chi-Chih Hung (106523)
Daw-Yang Hwang (343487)
Mei-Chuan Kuo (106525)
Yi-Wen Chiu (106535)
Jer-Ming Chang (106541)
Jer-Chia Tsai (106527)
Shang-Jyh Hwang (5312)
Julian L. Seifter (429125)
Hung-Chun Chen (106543)

July 2013

<p>Data expressed as mean ± standard deviation, median (interquartile range) or percentage.</p><p>AC...

Patient's medication.

Hiroki Sugiyama (351211)
Kazufumi Nakamura (336712)
Hiroshi Morita (124362)
Satoshi Akagi (351212)
Yoshinori Tani (351213)
Yusuke Katayama (351214)
Nobuhiro Nishii (351215)
Toru Miyoshi (341854)
Satoshi Nagase (351216)
Kunihisa Kohno (351217)
Kengo Fukushima Kusano (351218)
Tohru Ohe (351219)
Junko Kurokawa (253979)
Tetsushi Furukawa (253981)
Hiroshi Ito (297745)

February 2013

<p>ACEI/ARB: Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.</p

Medication use.

Colin D. Chue (136552)
Nadezhda A. Wall (319159)
Nicola J. Crabtree (319161)
Daniel Zehnder (291721)
William E. Moody (319163)
Nicola C. Edwards (319164)
Richard P. Steeds (319166)
Jonathan N. Townend (319167)
Charles J. Ferro (319168)

February 2013

<p>Data are frequency (percentage). ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin ...

Subgroup Analysis of ACEI and ARB: Regular versus Potentially Contaminated Heparin.

Heiko A. Kaiser (622132)
Arbi Ben Abdallah (176559)
Nan Lin (26755)
Bethany R. Tellor (622133)
Mohammad Helwani (622134)
Jennifer R. Smith (368977)
Marc R. Moon (622135)
Michael S. Avidan (622136)

August 2014

<p>ACEI indicates angiotensin-converting-enzyme inhibitor; ARB, angiotensin-receptor blocker.</p><p>...

Summary of patient selection.

Hon-Yen Wu (286645)
Chiao-Ling Peng (503342)
Pei-Chun Chen (194576)
Chih-Kang Chiang (135324)
Chee-Jen Chang (287558)
Jenq-Wen Huang (135317)
Yu-Sen Peng (315725)
Yu-Kang Tu (41946)
Tzong-Shinn Chu (141730)
Kuan-Yu Hung (286650)
Kuo-Liong Chien (73583)

May 2017

<p>ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.</p

Prescription of the recommended therapy.

Myriam L. Montminy (2156071)
Valerie Gauvin (2156065)
Stephane Turcotte (2156077)
Alain Milot (62252)
Yvan Douville (2156068)
Isabelle Bairati (2156074)

February 2016

<p>ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin receptor blocker; CAD, coronary a...

Subgroup analyses of the included studies.

Yuan Yang (151457)
Fan Zhang (46132)
Laura Skrip (474074)
Han Lei (417024)
Suxin Luo (646401)
Kai Lu (166354)
Dayi Hu (339675)

March 2015

<p>ARB: angiotensin receptor blocker; OR: odds ratios</p><p>Subgroup analyses of the included studie...

Cumulative proportion of the incidence of hospitalization owing to fractures.

Suguru Yamamoto (721661)
Ryo Kido (721662)
Yoshihiro Onishi (721663)
Shingo Fukuma (685099)
Tadao Akizawa (316095)
Masafumi Fukagawa (721664)
Junichiro J. Kazama (721665)
Ichiei Narita (156924)
Shunichi Fukuhara (316094)

April 2015

<p>ACEI: angiotensin converting enzyme inhibitor, ARB: angiotensin II receptor blocker.</p

Prevalence of statin and angiotensin-converting enzyme inhibitor (ACEI)/ angiotensin II receptor blocker (ARB) users in the pneumonia and control groups.

Jiunn-Horng Kang (427929)
Li-Ting Kao (409065)
Herng-Ching Lin (284636)
Ta-Jung Wang (5465276)
Tsung-Yeh Yang (2194069)

June 2018

<p>Prevalence of statin and angiotensin-converting enzyme inhibitor (ACEI)/ angiotensin II receptor ...

Baseline characteristics.

Chen-Ying Hung (608395)
Kuo-Yang Wang (599645)
Tsu-Juey Wu (459389)
Yu-Cheng Hsieh (599643)
Jin-Long Huang (599641)
El-Wui Loh (608396)
Ching-Heng Lin (512565)

August 2014

<p>ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; RH = resistan...

Medical management of coronary risk factors.

Ole Ahlehoff (283243)
Lone Skov (318332)
Gunnar Gislason (324410)
Jesper Lindhardsen (283245)
Søren Lund Kristensen (283241)
Lars Iversen (324412)
Stine Lasthein (324415)
Robert Gniadecki (189822)
Tomas Norman Dam (324417)
Christian Torp-Pedersen (103282)
Peter Riis Hansen (283251)

February 2013

*<p>ACE-1; angiotensin-converting enzyme inhibitor, ARB; Angiotensin II receptor blocker.</p

Treatment of hypertensive patients with high risk of CVD.

Guanyang Zou (287895)
Zhitong Zhang (733339)
John Walley (287897)
Weiwei Gong (487252)
Yunxian Yu (117562)
Ruying Hu (411617)
Jia Yin (287896)
Min Yu (120607)
Xiaolin Wei (287892)

May 2015

<p>*ACEi: Angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker</p><p>** ‘Types...

Concomitant medications use within 90 days of index discharge.

Szu-Heng Wang (761539)
Dong-Yi Chen (319219)
Yu-Sheng Lin (68720)
Chun-Tai Mao (651349)
Ming-Lung Tsai (651350)
Ming-Jer Hsieh (103100)
Chung-Chuan Chou (600857)
Ming-Shien Wen (319221)
Chun-Chieh Wang (600856)
I-Chang Hsieh (103109)
Kuo-Chun Hung (410861)
Tien-Hsing Chen (331860)

June 2015

<p>Values are n (%); ACEI = angiotensin-converting-enzyme inhibitor; ARB = angiotensin II receptor b...

August 2016

lockade of the renin angiotensin aldosterone system RAAS has been the mainstay in the management of ...